Cambiar Investors LLC Athenex, Inc. Transaction History

Cambiar Investors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $399,746 - $1.45 Million	-97,977 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$11.06 - $14.01 $36,221 - $45,882	-3,275 Reduced 3.23%	97,977 $1.08 Million
Q3 2020 Oct 21, 2020	SELL	$10.26 - $14.55 $10,608 - $15,044	-1,034 Reduced 1.01%	101,252 $1.23 Million
Q2 2020 Aug 03, 2020	SELL	$7.11 - $13.76 $7,053 - $13,649	-992 Reduced 0.96%	102,286 $1.41 Million
Q1 2020 Apr 30, 2020	BUY	$5.71 - $15.85 $179,236 - $497,531	31,390 Added 43.67%	103,278 $799,000
Q4 2019 Feb 06, 2020	SELL	$9.6 - $17.75 $33,657 - $62,231	-3,506 Reduced 4.65%	71,888 $1.1 Million
Q3 2019 Oct 17, 2019	BUY	$12.16 - $21.0 $916,791 - $1.58 Million	75,394 New	75,394 $917,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.